Report on US Clinical Chemistry and Immunodiagnostics Market 2014

1
2014 Strategies for the US Clinical Chemistry and
Immunodiagnostics Market
Published Date January 2014
No. of Pages 600
Price Single User US11500
Corporate User US25300
2
New Market Research Report on 2014 Strategies
for the US Clinical Chemistry and
Immunodiagnostics Market added to
ReportsnReports.com
2014 Strategies for the US Clinical Chemistry
and Immunodiagnostic Market is a new strategic
analysis of major business opportunities emerging
in the US clinical chemistry and immunodiagnostic
markets during the next five years. The report
explores future trends in the US market provides
estimates of the specimen, test and sales
volumes, as well as major suppliers sales and
market shares compares features of leading
analyzers profiles key competitors and
identifies specific product and marketing
opportunities emerging during the next five
years.The report provides five-year volume and
sales forecasts for over 100 clinical chemistry,
TDM, endocrine, cancer, immunoprotein and abused
drug assays performed in hospitals, commercial
laboratories, physician offices, and ambulatory
care centers, including controls, calibrators and
consumables. Rationale The clinical chemistry
and immunodiagnostic markets are undergoing
significant transformation, caused by convergence
of new and more stringent regulations advances
in diagnostic technologies, system engineering,
automation, and IT and intensifying competition.
Some segments, like routine chemistry, are
already resembling commodity markets, where
product positioning and cost per test are more
critical than underlying technology. This
evolving marketplace creates exciting
opportunities for a variety of new instruments,
reagent systems, and auxiliary products, such as
specimen preparation devices, controls, and
calibrators.
3
2014 Strategies for the US Clinical Chemistry and
Immunodiagnostics Market
Strategic Recommendations - New product
development opportunitieswith significant market
appeal. - Alternative market penetration
strategies. - Potential market entry barriers and
risks. Competitive Assessments - Strategic
assessments of major suppliers andemerging
market entrants, including their sales,
productportfolios, marketing tactics,
collaborativearrangements and new products in
RD. - The companies analyzed in the report
includeAbbott, AdnaGen, Agilent, Alere, Beckman
Coulter/Danaher,Biomedical Diagnostics,
bioMerieux, Bio-Rad, DiaSorin,Eiken,
Fujirebio/Innogenetics, IL, Kyowa
Medex,Ortho-Clinical Diagnotics, Roche, Siemens,
Sysmex,Thermo Fisher, Tosoh, Wako,
Wallac/PE. Buy a copy of this report _at_
http//www.reportsnreports.com/purchase.aspx?name
274345 .
Browse more research reports on Healthcare _at_
http//www.reportsnreports.com/market-research/hea
lthcare/ .
4
2014 Strategies for the US Clinical Chemistry and
Immunodiagnostics Market
Table of Contents I. Introduction II.
Worldwide Market and Technology Overview A.
Major Routine Chemistry Tests 1. Albumin 2.
Alkaline Phosphatase 3. ALT/SGPT 4. Ammonia 5.
Amylase 6. AST/SGOT 7. Bilirubin, Total 8.
Blood Gases 9. Blood Urea Nitrogen (BUN) 10.
Calcium 11. Cardio CRP 12. Cholesterol 13.
Cholinesterase 14. CRP Buy a copy of this
report _at_ http//www.reportsnreports.com/purchase.a
spx?name274345 .
Request Copy of this report_at_ http//www.reportsnre
ports.com/contacts/requestsample.aspx?name274345
.
5
About ReportsnReports
ReportsnReports.com is your single source for all
market research needs. Our database includes
250,000 syndicated market research reports from
100 leading global publishers covering in-depth
analysis of over 5000 micro markets. With
comprehensive information about the publishers
and their report methodology, data sources, etc.
we help you in your purchase decision by mapping
your information needs with the most relevant
available reports in our library. Connect with
us sales_at_reportsandreports.com 1 888 391 5441
Contact sales_at_reportsandreports.com for further
information.
Contact sales_at_reportsandreports.com for further
information.